A new era is born.
ACADIA Pharmaceuticals (ACAD) is a biotechnology developer of breakthrough therapies in neuroscience. Specifically, ACADIA markets Nuplazid for hallucinations and delusions associated with Parkinson's ...
With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia Pharmaceuticals into its first $1 billion sales year. Achieving the milestone ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback